Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Increased levels of hepcidin, the master regulator of iron homeostasis, contribute to the diversion of iron underlying the anemia of chronic disease. Yet hepcidin levels are low in anemia of chronic disease with concomitant true iron deficiency. Here we clarify the different underlying pathways regulating hepcidin expression under these conditions in vivo. DESIGN AND METHODS: We used rat models of iron deficiency anemia, anemia of chronic disease and anemia of chronic disease with concomitant true iron deficiency and investigated upstream signaling pathways controlling hepcidin transcription in the liver. Protein and mRNA levels of iron metabolism genes and genes involved in SMAD1/5/8 and STAT3 signaling were determined by RT-PCR, Western blotting and immunohistochemistry. RESULTS: SMAD1/5/8 phosphorylation and in parallel hepcidin mRNA expression were increased in anemia of chronic disease but significantly down-regulated in anemia of chronic disease with concomitant iron deficiency, either on the basis of phlebotomy or dietary iron restriction. Iron deficiency resulted in reduced bone morphogenetic protein-6 expression and impaired SMAD1/5/8 phosphorylation and trafficking, two key events for hepcidin transcription. Reduced SMAD1/5/8 activity in association with phlebotomy was paralleled by increased expression of the inhibitory factor, SMAD7, dietary iron restriction appeared to impair hepcidin transactivating SMAD pathways via reduction of membrane bound hemojuvelin expression. CONCLUSIONS: This study evaluated hepcidin signaling pathways in anemia of chronic disease with/without concomitant iron deficiency in vivo. While iron deficiency in general decreased bone morphogenetic protein-6 expression, phlebotomy or dietary iron restriction inhibited inflammation driven SMAD1/5/8 mediated hepcidin formation by different pathways, indicating alternate hierarchic signaling networks as a function of the mode and kinetics of iron deficiency. Nonetheless, iron deficiency inducible regulatory pathways can reverse inflammation mediated stimulation of hepcidin expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Self-citationTwo to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · cited 2×
“The interactions of BMPs with BMP receptors result in phosphorylation of a subset of SMAD proteins (SMAD1, SMAD5 and SMAD8) and subsequent formation of a heteromeric complex with SMAD4, which translocates to the nucleus and induces the transcription of target genes (32, 33) The activation of BMP signaling through the…”
BackgroundNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214 · cited 1×
“As a surrogate for erythropoietic activity, we determined serum erythropoietin levels which were of interest because erythropoietin has previously been demonstrated to inhibit hepcidin formation.(10,37,40) As shown in Table 2, SMAD7 levels correlate positively (r=0.”
BackgroundBone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Iron mediated induction of hepcidin expression is affected by the membrane bound peptide hemojuvelin (mHJV)(23) which has been characterized as a bone morphogenetic protein (BMP) co-receptor.(24) Recently, the membrane bound serine protease TMPRSS6 (Matriptase 2) has been shown to degrade membrane anchored HJV,(25-27)…”
BackgroundRegulation of cellular iron metabolism
Wang, J., & Pantopoulos, K. (2011) · Biochemical Journal · doi:10.1042/bj20101825 · Cited by 986 · cited 1×
“7 In addition to iron and inflammation, the expression of hepcidin is controlled by hypoxia, endoplasmatic reticulum stress, erythropoietic activity and erythropoiesis driven signals (25, 35-40).”
BackgroundInterleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974 · cited 1×
“Iron mediated induction of hepcidin expression is affected by the membrane bound peptide hemojuvelin (mHJV) (23), which has been characterized as a bone morphogenetic protein (BMP) co-receptor (24).”
BackgroundHigh levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854 · cited 1×
“7 In addition to iron and inflammation, the expression of hepcidin is controlled by hypoxia, endoplasmatic reticulum stress, erythropoietic activity and erythropoiesis driven signals (25, 35-40).”
BackgroundBMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769 · cited 1×
“In addition, BMPs were characterized as potent inducers of hepcidin formation,(28,29) and genetic ablation of BMP6 resulted in tissue iron overload as a consequence of reduced hepcidin expression.(30,31) The interactions of BMPs with BMP receptors result in phosphorylation of a subset of SMAD proteins (SMAD1, SMAD5 an…”
BackgroundRegulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639 · cited 1×
“7 In addition to iron and inflammation, the expression of hepcidin is controlled by hypoxia, endoplasmatic reticulum stress, erythropoietic activity and erythropoiesis driven signals (25, 35-40).”
BackgroundA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 4×
“In addition, transcriptional activation of hepcidin is not only abrogated in SMAD4-deficient hepatocytes in response to iron overload and BMPs but also in response to IL-6 (48), indicating that the BMP/SMAD pathway is able to modulate the IL-6 inducible STAT3 pathway.”
BackgroundInfluentialLack of the bone morphogenetic protein BMP6 induces massive iron overload
Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., & Roth, M.-P. (2009) · Nature Genetics · doi:10.1038/ng.320 · Cited by 587
The serine protease TMPRSS6 is required to sense iron deficiency
Du, X., She, E., Gelbart, T., Truksa, J., Lee, P., Xia, Y., Khovananth, K., Mudd, S., Mann, N., Moresco, E. M. Y., et al. (2008) · Science · doi:10.1126/science.1157121 · Cited by 578
STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation
Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W., & Muckenthaler, M. U. (2007) · Blood · doi:10.1182/blood-2006-07-033969 · Cited by 567
Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., & Camaschella, C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.012 · Cited by 555 · cited 15×
“A B C D E F G H I Re la tiv e ab un da nc e he pc id in /G us b Re la tiv e ab un da nc e SM AD 7/ Gu sb m HJ V/ b -a ct in Re la tiv e ab un da nc e HJ V/ Gu sb Re la tiv e ab un da nc e BM P6 /G us b SM AD 7/ b -a ct in pS M AD 1/ 5/ 8/ SM AD 5 P<0.001 P<0.001 P<0.001 P<0.001 P<0.001 P<0.05 P<0.05P<0.05P<0.001 P<0.0…”
BackgroundInfluentialTime-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS
Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H., & Swinkels, D. (2005) · Blood · doi:10.1182/blood-2005-03-1159 · Cited by 498
Kautz, L., Meynard, D., Monnier, A., Darnaud, V., Bouvet, R., Wang, R.-H., Deng, C., Vaulont, S., Mosser, J., Coppin, H., et al. (2008) · Blood · doi:10.1182/blood-2008-03-143354 · Cited by 437 · cited 1×
“This is in accordance with data showing that STAT3 inducible hepcidin expression is influenced by BMP dependent SMAD activation but not vice versa(46) and with data indicating that SMAD1/5/8 phosphorylation is affected by iron status.(47) In addition, transcriptional activation of hepcidin is not only abrogated in SMA…”
ResultCytokine-mediated regulation of iron transport in human monocytic cells
Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood · doi:10.1182/blood-2002-08-2459 · Cited by 420
Self-citationDetection, evaluation, and management of iron-restricted erythropoiesis
Goodnough, L. T., Nemeth, E., & Ganz, T. (2010) · Blood · doi:10.1182/blood-2010-05-286260 · Cited by 410 · cited 1×
“deficiency anemia (IDA) as a consequence of chronic blood loss (ACD/IDA) (1, 17, 18) The differentiation between ACD and ACD/IDA is of clinical importance because”
BackgroundHepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages
GANZ, T. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.020 · Cited by 393 · cited 4×
“We and others reported increased hepcidin expression in patients suffering from ACD and in mammalian models mimicking ACD.7,13,14,19 In contrast, serum hepcidin levels and/or liver Hamp mRNA expression were significantly lower in patients and mammals suffering from ACD with true iron deficiency (ACD/IDA) when compared…”
BackgroundResultInfluentialTLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens
Peyssonnaux, C., Zinkernagel, A. S., Datta, V., Lauth, X., Johnson, R. S., & Nizet, V. (2006) · Blood · doi:10.1182/blood-2005-06-2259 · Cited by 379 · cited 1×
“This effect is further aggravated in inflammatory macrophages/monocytes by the autocrine formation of hepcidin.(11,12) The role of hepcidin in the pathogenesis of human ACD is supported by the finding that hepcidin levels: i) are significantly increased in patients with ACD(7,13) and in subjects injected with LPS;(14)…”
BackgroundSTAT3 Is Required for IL-6-gp130–Dependent Activation of Hepcidin In Vivo
Pietrangelo, A., Dierssen, U., Valli, L., Garuti, C., Rump, A., Corradini, E., Ernst, M., Klein, C., & Trautwein, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.018 · Cited by 315
ER Stress Controls Iron Metabolism Through Induction of Hepcidin
Vecchi, C., Montosi, G., Zhang, K., Lamberti, I., Duncan, S. A., Kaufman, R. J., & Pietrangelo, A. (2009) · Science · doi:10.1126/science.1176639 · Cited by 310 · cited 1×
“7 In addition to iron and inflammation, the expression of hepcidin is controlled by hypoxia, endoplasmatic reticulum stress, erythropoietic activity and erythropoiesis driven signals (25, 35-40).”
BackgroundTruksa, J., Peng, H., Lee, P., & Beutler, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603124103 · Cited by 309 · cited 1×
“In addition, BMPs were characterized as potent inducers of hepcidin formation (28, 29), and genetic ablation of BMP6 resulted in tissue iron overload as a consequence of reduced hepcidin expression (30, 31).”
BackgroundAutocrine formation of hepcidin induces iron retention in human monocytes
Theurl, I., Theurl, M., Seifert, M., Mair, S., Nairz, M., Rumpold, H., Zoller, H., Bellmann-Weiler, R., Niederegger, H., Talasz, H., et al. (2008) · Blood · doi:10.1182/blood-2007-05-090019 · Cited by 275 · cited 3×
“This effect is further aggravated in inflammatory macrophages/monocytes by the autocrine formation of hepcidin.(11,12) The role of hepcidin in the pathogenesis of human ACD is supported by the finding that hepcidin levels: i) are significantly increased in patients with ACD(7,13) and in subjects injected with LPS;(14)…”
BackgroundMethodSelf-citationSasu, B. J., Cooke, K. S., Arvedson, T. L., Plewa, C., Ellison, A. R., Sheng, J., Winters, A., Juan, T., Li, H., Begley, C. G., et al. (2010) · Blood · doi:10.1182/blood-2009-09-245977 · Cited by 251 · cited 1×
“The role of hepcidin in the pathogenesis of human ACD is supported by the finding that hepcidin levels: i) are significantly increased in patients with ACD(7,13) and in subjects injected with LPS;(14) ii) are correlated to iron retention in monocytes/macrophages in vivo;(15) and iii) by the observation that administra…”
BackgroundRegulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation
Yang, F., Liu, X.-B., Quinones, M., Melby, P. C., Ghio, A., & Haile, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201485200 · Cited by 197 · cited 1×
“This diversion of iron traffic is induced via regulatory effects of cytokines on iron uptake and release by macrophages (5, 6) and by the activity of the iron and cytokine inducible liver derived”
BackgroundTheurl, I., Mattle, V., Seifert, M., Mariani, M., Marth, C., & Weiss, G. (2006) · Blood · doi:10.1182/blood-2005-08-3364 · Cited by 188 · cited 1×
“finding that hepcidin levels (i) are significantly increased in patients with ACD (7, 13) and in subjects injected with LPS (14), (ii) are correlated to iron retention in monocytes/macrophages in vivo (15) and (iii) by the observation that administration”
BackgroundSelf-citationCasanovas, G., Mleczko-Sanecka, K., Altamura, S., Hentze, M. W., & Muckenthaler, M. U. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0447-2 · Cited by 161 · cited 2×
“reversed in vivo by the regulatory cascades induced by true iron deficiency (46, 48).”
BackgroundResultLudwiczek, S., Theurl, I., Artner-Dworzak, E., Chorney, M., & Weiss, G. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0542-3 · Cited by 57
Self-citationIron and inflammation: cross-talk between pathways regulating hepcidin
Fleming, R. E. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0349-8 · Cited by 54
Cited by
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
Self-citationRegulation of iron transport and the role of transferrin
Gkouvatsos, K., Papanikolaou, G., & Pantopoulos, K. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.10.013 · Cited by 518
Besson-Fournier, C., Latour, C., Kautz, L., Bertrand, J., Ganz, T., Roth, M.-P., & Coppin, H. (2012) · Blood · doi:10.1182/blood-2012-02-411470 · Cited by 179
The liver: conductor of systemic iron balance
Meynard, D., Babitt, J. L., & Lin, H. Y. (2014) · Blood · doi:10.1182/blood-2013-06-427757 · Cited by 177
“Indeed, increased liver SMAD1/5/8 phosphorylation has been observed in mice with anemia of inflammation in addition to increased STAT3 phosphorylation.(94) More recently, Besson-Fournier et al have suggested that the BMP/TGF-b superfamily ligand participating in the SMAD1/5/8 pathway activation in response to LPS inje…”
BackgroundAnaemia in inflammatory rheumatic diseases
Weiss, G., & Schett, G. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.183 · Cited by 146
Self-citation
Metadata
- Authors
- Theurl, I., Schroll, A., Nairz, M., Seifert, M., Theurl, M., Sonnweber, T., Kulaksiz, H., & Weiss, G.
- Venue
- Haematologica
- Published
- 2011-08-22
- Volume
- 96
- Issue
- 12
- Pages
- 1761-1769
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2104896102
- Cited by
- 76
- References
- 31
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.